Cargando…
Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library
Lujo virus (LUJV) belongs to the Old World (OW) genus Mammarenavirus (family Arenaviridae). It is categorized as a biosafety level (BSL) 4 agent. Currently, there are no U.S. Food and Drug Administration (FDA)-approved drugs or vaccines specifically for LUJV or other pathogenic OW mammarenaviruses....
Autores principales: | Cao, Junyuan, Dong, Siqi, Liu, Yang, Zhou, Minmin, Guo, Jiao, Jia, Xiaoying, Zhang, Yueli, Hou, Yuxia, Tian, Ming, Xiao, Gengfu, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675865/ https://www.ncbi.nlm.nih.gov/pubmed/34925303 http://dx.doi.org/10.3389/fmicb.2021.793519 |
Ejemplares similares
-
Screening and Identification of Lassa Virus Entry Inhibitors from a Fragment-Based Drug Discovery Library
por: Hou, Yuxia, et al.
Publicado: (2022) -
Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library
por: Wang, Peilin, et al.
Publicado: (2018) -
Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19
por: Cao, Junyuan, et al.
Publicado: (2022) -
Screening of Botanical Drugs against Lassa Virus Entry
por: Liu, Yang, et al.
Publicado: (2021) -
Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration
por: Jiao, Kuo, et al.
Publicado: (2019)